_256_384.jpg)
Drug Approval | April 07, 2024
Cipla Patalganga facility gets 6 USFDA observations
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
The observations are procedural in nature and will be responded to within the stipulated time
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
A five-day inspection was concluded successfully with no critical and no major observations raised
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
ANVISA issues CGMP to Concord Biotech’s Unit I
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
Cipla completes transfer of Generics Business Undertaking
Subscribe To Our Newsletter & Stay Updated
